PHAR 328.01: Antimicrobial Agents by Freeman, David S.
University of Montana
ScholarWorks at University of Montana
Syllabi Course Syllabi
Spring 1-2003
PHAR 328.01: Antimicrobial Agents
David S. Freeman
University of Montana - Missoula
Let us know how access to this document benefits you.
Follow this and additional works at: https://scholarworks.umt.edu/syllabi
This Syllabus is brought to you for free and open access by the Course Syllabi at ScholarWorks at University of Montana. It has been accepted for
inclusion in Syllabi by an authorized administrator of ScholarWorks at University of Montana. For more information, please contact
scholarworks@mso.umt.edu.
Recommended Citation
Freeman, David S., "PHAR 328.01: Antimicrobial Agents" (2003). Syllabi. 4290.
https://scholarworks.umt.edu/syllabi/4290
PHARMACY 328 (ANTIMICROBIAL AGENTS) SPRING SEMESTER, 2003
INSTRUCTOR: David Freeman, Office - SB 308 Office Phone: 243-4772 Home Phone: 728-6551 
E-mail: dfreeman@selwav.umt.edu
EXAMS AND GRADING:
First Exam: Tuesday, MARCH 4  50 points
Second Exam: Thursday, APRIL 3  70 points
Third Exam: Thursday, MAY 1  80 points
Final Exam:  100 points
10 Point Quizzes: Best 5 or 6 out of 6 scores . . 50 or 60 points
Total Points: 350, or 360 90-100% = A 80-89 % = B 70-79 % = C 65-69 % = D
* All EXAMS are comprehensive
* All exams and quizzes must be taken at scheduled times
* Instructor must be informed BEFORE missing a scheduled exam period 
and MUST be based on GOOD REASONS
* Missed exam periods must be made up within 2 days
* No make up quizzes
STUDENT PERFORMANCE OBJECTIVES:
1) Know the normal relevant biochemical pathways and the major biochemical mechanisms
of action for the different classes of drugs
2) Know the biochemical mechanisms involved in the development of resistance to different
classes of antimicrobial agents
3) Given a representative chemical structure or name of a drug, know its biochemical mechanisms
of action and for development of resistance
4) Given a representative chemical structure or name of a drug, know its major chemical,
pharmacologic, or therapeutic categorization
5) Given a representative chemical structure or name of a drug, know its major
therapeutic uses and spectrum of activity
6) Given a representative chemical structure or name of a drug, know important aspects of its
absorption, pharmacokinetics, and metabolism
7) Know important chemical features (i.e., polar or lipophilic properties, labile groups, etc.) that
affect the absorption, distribution, metabolism, elimination, potency, stability, or formulation 
of a class of antimicrobial agents
8) Given the chemical structure of an antimicrobial agent, know important chemical changes
that will predictably alter its properties (i.e., potency, duration of action, stability, etc.)
9) Given a representative chemical structure or name of a drug, know its most common or serious
adverse or side effects
REQUIRED TEXT: Goodman & Gilman, "The Pharmacological Basis of Therapeutics", Tenth Edition
Reading 
in Text
1143-1159 I. General Considerations, Categorization, and
Table 43-1 Sensitivity Testing of Antimicrobial Agents
The following areas will be covered for each outline topic below:
-General Chemical Structures and Properties of Agents 
-Biochemical Mechanisms of Action for Agents
-Biochemical Mechanisms Involved in the Development of Microbial Resistance 
-Important Aspects of Absorption, Distribution, Metabolism, and Elimination for Agents 
-Antimicrobial Spectrum of Activity for Agents 
-Important Adverse Effects and Drug Interactions for Agents
Reading
in Text
II. Antibacterial Agents
1171-1179 A. Sulfonamides and TRIMETHOPRIM
1179-1183 B. Quinolones, Fluoroquinolones
1184-1185 C. NITROFURANTOIN and METHENAMINE
D. Beta-lactam Antibiotics
1189-1205 1. Penicillins
1214-1215 2. Beta-lactamase inhibitors (CLAVULANIC ACID, SULBACTAM, TAZOBACTAM)
1206-1213 3. Cephalosporins
1213-1214 4. Carbapenems (IMIPENEM), Carbacephems (LORACARBEF),
Monobactams (AZTREONAM)
1261-1266 E. SPECTINOMYCIN, POLYMYXIN, VANCOMYCIN, TEICHOPLANIN, BACITRACIN
1219-1234 F. Aminoglycosides
1239-1246 G. Tetracyclines
1250-1256 H. Macrolides (ERYTHROMYCIN, AZITHROMYCIN, CLARITHROMYCIN)
1246-1250 I. CHLORAMPHENICOL 
1256-1258 J. CLINDAMYCIN
1258-1259 K. Streptogramins (QUINUPRISTIN, DALFOPRISTIN)
1260-1261 L. Oxazolidinones (LINEZOLID)
1105-1108 M. METRONIDAZOLE
III. Anti-mycobacterial Agents
1273-1282 A. Drugs for Tuberculosis
* ISONIAZID RIFAMPIN PYRAZINAMIDE ETHAMBUTOL *
B. Drugs for Mycobacterium Avium Complex1286-1288
IV. Antifungal Agents
A. AMPHOTERICIN B and FLUCYTOSINE
B. Imidazole and Triazole Antifungal Agents (azoles)
* KETOCONAZOLE ITRACONAZOLE FLUCONAZOLE VORICONAZOLE *
1305-1306 C. GRISEOFULVIN and TERBINAFINE and CASPOFUNGIN
1307-1310 D. Topical Antifungal Agents
* CLOTRIMAZOLE MICONAZOLE TOLNAFTATE NAFTIFINE *
* NYSTATIN UNDECYLENIC ACID *
V. Antiviral Agents
1313-1317 A. Overview of Viral DNA and RNA Biochemical Processes
1295-1300
1301-1305
B. Overview of Biochemical Mechanisms of Action and Resistance Development
C. Non-HIV Antiviral Agents
* ACYCLOVIR VALACYCLOVIR CIDOFOVIR DOCOSANOL *
* FAMCICLOVIR PENCICLOVIR FOSCARNET GANCICLOVIR*
* VALGANCICLOVIR TRIFLURIDINE VIDARABINE *
1329-1332 D. Antiinfluenza Agents * AMANTADINE RIMANTIDINE OSELTAMIVIR ZANAMIVIR *
1332-1340 E. Other Antiviral Agents
1317-1319
1317-1328
VI. HIV Antiviral Agents
A. Overview of HIV Infection
B. Nucleoside Reverse Transcriptase Inhibitors * ZIDOVUDINE DIDANOSINE
STAVUDINE ZALCITABINE LAMIVUDINE ABACAVIR TENOFOVIR *
C. Nonnucleoside Reverse Transcriptase Inhibitors
* NEVIRAPINE DELAVIRDINE EFAVIRENZ *
D. Protease Inhibitors
* SAQUINAVIR INDINAVIR RITONAVIR NELFINAVIR AMPRENAVIR*
1349-1353
1353-1360
1360-1363
1364-1373
1076, 1109-1111
E. Drugs for Opportunistic Infections
* ATOVAQUONE PENTAMIDINE *
